MeSH | Herpes Zoster (D006562)

Herpes Zoster D006562

Diseases [C] » Infections [C01] » Virus Diseases » DNA Virus Infections » Herpesviridae Infections » Varicella Zoster Virus Infection » Herpes Zoster

Description

An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed) MeSH

Hierarchy View

View MeSH Tree View ICD-10 Tree

Subtype Terms (3)

Herpes Zoster Ophthalmicus
4 approved drugs

Herpes Zoster Oticus

Zoster Sine Herpete

Approved Indicated Drugs (4)

aciclovir (zovirax)

famciclovir (famvir)

subunit herpes zoster vaccine

valaciclovir (Valtrex)

Phase 4 Indicated Drugs (6)

foscarnet (foscavir)

gabapentin (neurontin)

gelatin

live attenuated varicella vaccine (Varivax)

pregabalin (lyrica)

varicella zoster virus glycoprotein e antigen (Shingrix)

Phase 3 Indicated Drugs (16)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23)

amenamevir

capsaicin (qutenza)

desipramine (pertofrane)

diphtheria, tetanus and whole cell pertussis vaccine (Boostrix)

fv-100

gsk2186877a

inactivated influenza vaccine

interferon alpha-2b (Intron-A)

live, attenuated herpes zoster vaccine (varilrix)

methadone (methadose)

morphine

mrna-1273 (Spikevax)

nortriptyline (aventyl)

pneumococcal 13-valent conjugate vaccine (prevnar 13)

v212

Phase 2 Indicated Drugs (12)

autologous adipose-derived mesenchymal stem cells

autologous muscle derived stem cells

carisbamate

crv-101

dextromethorphan (delsym)

valomaciclovir stearate

Phase 1 Indicated Drugs (8)

Other Experimental Indicated Drugs (1)

oxycodone (oxycontin)

Organization Involved with Phase 4 Indications (47)

AstraZeneca

Boston University

B.P. Koirala Institute of Health Sciences

Canadian Institutes of Health Research (CIHR)

Centers for Disease Control and Prevention (CDC)

Changchun Keygen Biological Products Co., Ltd.

China National Biotec Group Co., Ltd

Chulalongkorn University

Department of Veteran Affairs

Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd

Kenyan AIDS Vaccine Initiative

Ludwig Maximilians University

Merck

National Eye Institute (NEI)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute on Aging (NIA)

National Institutes of Health (NIH)

Taichung Veterans General Hospital

Tanta University

Technical University of Munich

The Guenther Dermatology Research Centre

The HIV Netherlands Australia Thailand Research Collaboration

Tulane University

University of Colorado

University of Colorado, Denver

University of Nairobi

University of the Witwatersrand

University of Toronto

University of Washington

University of Wisconsin

Vabiotech

Vietnam Military Medical University

Yung Shin Pharm. Ind. Co., Ltd.

ZonMw: The Netherlands Organisation for Health Research and Development

Organization Involved with Phase 3 Indications (15)

Changchun BCHT Biotechnology Co.

De La Salle University

EMS S/A

Hepion Pharmaceuticals

Johns Hopkins University

Korea University

Maruho Co., Ltd.

Mundipharma

National Center for Research Resources (NCRR)

National Institute of Neurological Disorders and Stroke (NINDS)

NeurogesX

Sinovac Biotech Co., Ltd

SK Chemicals

University of Geneva

University of Sao Paulo

Organization Involved with Phase 2 Indications (25)

Adult AIDS Clinical Trials Group

aRigen Pharmaceuticals, Inc.

Capital Medical University

National Heart, Lung, and Blood Institute (NHLBI)

National Institute of Dental and Craniofacial Research (NIDCR)

Nobel Pharmaceuticals

Northwestern University

Oregon Health and Science University

Pfizer

Renovis

Shahid Beheshti University of Medical Sciences

University of Alabama, Birmingham

University of California, San Diego

University of California, San Francisco

University of Sydney

University of Texas at Houston

University of Zurich

Organization Involved with Phase 1 Indications (16)

Baylor University

Centrexion Therapeutics

Cooperative Clinical Trials in Pediatric Transplantation

Curevo Inc

EyeGene Inc.

Green Cross Corporation

Immune Design

Mogam Biotechnology Research Institute

North American Pediatric Renal Transplantation Study (NAPRTCS)

Novotech

Nucleus Network Ltd

Oklahoma Medical Research Foundation

The Center for Pharmaceutical Research

University of Cincinnati

University of Oklahoma

University of Rochester

Organization Involved with Other Experimental Indications (10)

Cangene

Center for Clinical Studies, Texas

Seoul National University

The University of Hong Kong

The University of Texas, Dallas

Zhejiang University

Hierarchy Tree View

MeSH
ICD-10

UMLS Data

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.